Charles River Valuation
| CRL Stock | USD 183.70 17.92 8.89% |
At this time, the firm appears to be fairly valued. Charles River Labora shows a prevailing Real Value of $176.75 per share. The current price of the firm is $183.7. Our model approximates the value of Charles River Labora from analyzing the firm fundamentals such as profit margin of (0.02) %, and Return On Equity of -0.0219 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Charles River's valuation include:
Price Book 2.9138 | Enterprise Value | Enterprise Value Ebitda 23.9032 | Price Sales 2.2469 | Forward PE 18.7617 |
Fairly Valued
Today
Please note that Charles River's price fluctuation is very steady at this time. Calculation of the real value of Charles River Labora is based on 3 months time horizon. Increasing Charles River's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Charles stock is determined by what a typical buyer is willing to pay for full or partial control of Charles River Laboratories. Since Charles River is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Charles Stock. However, Charles River's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 183.7 | Real 176.75 | Target 215.73 | Hype 184.93 | Naive 169.82 |
The intrinsic value of Charles River's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Charles River's stock price.
Estimating the potential upside or downside of Charles River Laboratories helps investors to forecast how Charles stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Charles River more accurately as focusing exclusively on Charles River's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Charles River's intrinsic value based on its ongoing forecasts of Charles River's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Charles River's closest peers.
Charles River Cash |
|
Charles Revenue by Product
Charles River Total Value Analysis
Charles River Laboratories is currently projected to have company total value of 12.34 B with market capitalization of 9.04 B, debt of 2.72 B, and cash on hands of 194.61 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Charles River fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
12.34 B | 9.04 B | 2.72 B | 194.61 M |
Charles River Investor Information
About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Charles River was currently reported as 69.19. The company has Price/Earnings To Growth (PEG) ratio of 0.15. Charles River Labora recorded a loss per share of 1.52. The entity had not issued any dividends in recent years. Based on the analysis of Charles River's profitability, liquidity, and operating efficiency, Charles River Laboratories may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.14 | 0.17 |
|
| |||||
| Total Cash From Operating Activities | 887 M | 844.8 M |
|
| |||||
| Operating Income | 214.9 M | 261.4 M |
|
|
Charles River Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Charles River has an asset utilization ratio of 53.8 percent. This suggests that the Company is making $0.54 for each dollar of assets. An increasing asset utilization means that Charles River Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.Charles River Profitability Analysis
Considering Charles River's profitability and operating efficiency indicators, Charles River Laboratories may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Charles River's ability to earn profits and add value for shareholders.Net Income | First Reported 2000-03-31 | Previous Quarter 52.3 M | Current Value 54.4 M | Quarterly Volatility 91.4 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.41 | 0.42 |
|
| |||||
| Net Profit Margin | 0.11 | 0.1 |
|
| |||||
| Operating Profit Margin | 0.14 | 0.17 |
|
| |||||
| Pretax Profit Margin | 0.12 | 0.16 |
|
| |||||
| Return On Assets | 0.0262 | 0.0521 |
|
| |||||
| Return On Equity | 0.12 | 0.132 |
|
|
For Charles River profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Charles River Labora to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Charles River utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Charles River's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Charles River over time as well as its relative position and ranking within its peers.
Charles River Earnings per Share Projection vs Actual
The next projected EPS of Charles River is estimated to be 2.73835 with future projections ranging from a low of 2.5875 to a high of 3.08965. Charles River's most recent 12-month trailing earnings per share (EPS TTM) is at -1.52. Please be aware that the consensus of earnings estimates for Charles River Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.Charles River Earnings Estimation Breakdown
The calculation of Charles River's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Charles River is estimated to be 2.73835 with the future projection ranging from a low of 2.5875 to a high of 3.08965. Please be aware that this consensus of annual earnings estimates for Charles River Laboratories is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
2.59 Lowest | Expected EPS | 3.09 Highest |
Charles River Earnings Projection Consensus
Suppose the current estimates of Charles River's value are higher than the current market price of the Charles River stock. In this case, investors may conclude that Charles River is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Charles River's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 18 | 87.12% | 0.0 | 2.73835 | -1.52 |
Charles River Ownership Allocation
The majority of Charles River Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Charles River Labora to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Charles River. Please pay attention to any change in the institutional holdings of Charles River Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that on December 5, 2019, Representative Susie Lee of US Congress acquired under $15k worth of Charles River Labora's common stock.Charles River Profitability Analysis
The company reported the last year's revenue of 4.05 B. Total Income to common stockholders was 25.29 M with profit before taxes, overhead, and interest of 1.4 B.About Charles River Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Charles River Laboratories. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Charles River Labora based exclusively on its fundamental and basic technical indicators. By analyzing Charles River's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Charles River's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Charles River. We calculate exposure to Charles River's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Charles River's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.5 B | 1.6 B | |
| Pretax Profit Margin | 0.16 | 0.12 | |
| Operating Profit Margin | 0.17 | 0.14 | |
| Net Profit Margin | 0.10 | 0.11 | |
| Gross Profit Margin | 0.42 | 0.41 |
Charles River Growth Indicators
Investing in growth stocks can be very risky. If the company such as Charles River does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 51.6 M | |
| Quarterly Earnings Growth Y O Y | -0.173 | |
| Forward Price Earnings | 18.7617 |
Charles River Current Valuation Indicators
Charles River's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Charles River's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Charles River, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Charles River's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Charles River's worth.When determining whether Charles River Labora is a strong investment it is important to analyze Charles River's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Charles River's future performance. For an informed investment choice regarding Charles Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. Projected growth potential of Charles fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Charles River assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.17) | Earnings Share (1.52) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
Understanding Charles River Labora requires distinguishing between market price and book value, where the latter reflects Charles's accounting equity. The concept of intrinsic value - what Charles River's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Charles River's price substantially above or below its fundamental value.
It's important to distinguish between Charles River's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Charles River should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Charles River's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.